Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02063048 · ClinicalTrials.gov registry record · NA
Text Messaging for Weight Loss
A NA study of PreDiabetes and Body Weight, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- NA
- Development phase
- 163
- Enrollment target
- 1
- Study location
NCT02063048: Completed NA study of PreDiabetes and Body Weight, sponsored by Denver Health and Hospital Authority.
NCT02063048 is a NA study of PreDiabetes and Body Weight that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 163 participants, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02063048, a NA study of PreDiabetes and Body Weight, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- NA
- Development phase
- 163 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare the effectiveness of text message-based support to usual care at promoting weight loss in patients with pre-diabetes.
Primary Outcome
Outcomes will be analyzed at baseline and at 6-month and 12-month follow-ups.
Conditions Studied
Interventions
- BEHAVIORAL Text Message Based Weight Loss Support
Study Locations (1)
Colorado
- Denver Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-05 |
| Phase | NA |
What the finished NCT02063048 record still lists
NCT02063048 is an interventional study that assigns participants to a tested intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 700-participant average among 149 other PreDiabetes trials with a reported enrollment target (77% lower).
The record links to 4 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which Text Message Based Weight Loss Support is the first listed.
NCT02063048 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT02063048 about?
NCT02063048 is a clinical study titled "Text Messaging for Weight Loss". The purpose of this study is to compare the effectiveness of text message-based support to usual care at promoting weight loss in patients with pre-diabetes.
What is the current status of trial NCT02063048?
This trial is currently completed. It is a NA study. The enrollment target is 163 participants. The study started on 2014-04. Estimated completion is 2015-05.
What conditions does trial NCT02063048 study?
This clinical trial studies the following conditions: PreDiabetes, Body Weight, Prediabetic State, Body Weight Changes.
What interventions are being tested in trial NCT02063048?
The interventions under investigation include: Text Message Based Weight Loss Support (BEHAVIORAL).
Who is sponsoring clinical trial NCT02063048?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02063048 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PreDiabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02063048's enrollment target sits among peer trials
163 46th of 149 higher than 104 of 149 other PreDiabetes trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Black Impact: The Mechanisms Underlying Psychosocial Stress Reduction in a Cardiovascular Health Intervention
RECRUITING · NA
-
Diabetes Clinical Decision Support
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
-
Cleaner Air for Lower Cardiometabolic Risk
RECRUITING · NA
-
Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia